OncLive® On Air cover image

S13 Ep42: Endometrial (Uterine) Cancer 2025 UPDATE

OncLive® On Air

00:00

Frontline Systemic Regimens and Immunotherapy Addition

Kareen summarizes carboplatin-paclitaxel doublet and new additions of pembrolizumab or dostarlimab; dMMR-specific options noted.

Play episode from 05:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app